Literature DB >> 28374419

The acute-phase mediator serum amyloid A is associated with symptoms of depression and fatigue.

E Y Bryleva1, S A Keaton1,2,3, J Grit1, Z Madaj4, A Sauro-Nagendra1, L Smart5, S Halstead5, E Achtyes2,5, L Brundin1,5.   

Abstract

OBJECTIVE: Establish whether inflammatory biomarkers-serum amyloid A (SAA), C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)-are related to key symptoms of depression, including anxiety and fatigue, in a cross-sectional, out-patient setting to identify biomarkers that reflect psychiatric symptomatology in a naturalistic, real-life population.
METHODS: We measured SAA, CRP, IL-6, and TNF-α in plasma samples from 89 adult psychiatric out-patients by multiplex, high-sensitivity electrochemiluminescent assays. Psychiatric symptoms were evaluated using the Hamilton Depression Rating Scale (HAMD-17), the Patient Health Questionnaire (PHQ-9), and the Center for Epidemiological Studies Depression Scale (CES-D).
RESULTS: Plasma SAA was most robustly associated with depressive symptoms across diagnostic boundaries in this cohort of out-patients. Elevated SAA was significantly associated with higher total scores on the HAMD-17 scale and correlated with multiple scale items that rated symptoms of fatigue and depressed mood, but not with anxiety-related items.
CONCLUSIONS: SAA might constitute a cross-diagnostic marker indicative of depressed mood and fatigue in a naturalistic patient setting. Because SAA activates Toll-like receptors 2 and 4, present on macrophages and glial cells, its association with depression severity could also implicate this inflammatory mediator in the pathogenesis of mood disorders.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  C-reactive protein; biomarker; inflammation; interleukin-6; mood disorders

Mesh:

Substances:

Year:  2017        PMID: 28374419     DOI: 10.1111/acps.12730

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  7 in total

1.  An inflammatory profile linked to increased suicide risk.

Authors:  Sarah A Keaton; Zachary B Madaj; Patrick Heilman; LeAnn Smart; Jamie Grit; Robert Gibbons; Teodor T Postolache; Kimberly Roaten; Eric D Achtyes; Lena Brundin
Journal:  J Affect Disord       Date:  2019-01-03       Impact factor: 4.839

Review 2.  Inflammatory markers and depression in Parkinson's disease: a systematic review.

Authors:  Luis Guilherme Ramanzini; Luís Fernando Muniz Camargo; Juliana Oliveira Freitas Silveira; Guilherme Vargas Bochi
Journal:  Neurol Sci       Date:  2022-08-30       Impact factor: 3.830

3.  IL-10: A possible immunobiological component of positive mental health in refugees.

Authors:  Sarah A Keaton; Judy Arnetz; Hikmet Jamil; Abir Dhalimi; Paul M Stemmer; Douglas M Ruden; Jolin Yamin; Eric Achtyes; LeAnn Smart; Lena Brundin; Bengt B Arnetz
Journal:  Compr Psychoneuroendocrinol       Date:  2021-11-12

4.  Efficacy of montmorillonite and vitamin AD combined with zinc preparation in children with diarrheal disease and its effect on inflammatory factors.

Authors:  Zhen Wang; Ya Wang; Yan Hu; Miaomiao Chen; Ting Li
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

5.  Combined repetitive transcranial magnetic stimulation and medication treatment for depression is associated with serum amyloid a level: Evidence from naturalistic clinical practice.

Authors:  You Xu; Li Han; Youdan Wei; Hongjing Mao; Zhenghe Yu
Journal:  Front Neurosci       Date:  2022-09-14       Impact factor: 5.152

6.  Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination.

Authors:  Manish K Jha; Abu Minhajuddin; Bharathi S Gadad; Madhukar H Trivedi
Journal:  Int J Neuropsychopharmacol       Date:  2017-11-01       Impact factor: 5.176

Review 7.  Study on the Correlation Between NF-κB and Central Fatigue.

Authors:  Xingzhe Yang; Feng Li; Yan Liu; Danxi Li; Jie Li
Journal:  J Mol Neurosci       Date:  2021-02-14       Impact factor: 3.444

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.